Showing results (1001-1010 of 1,044) with videos related to
Sort By:
Pageof 105
Nature Communications|February 2, 2021
Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitorsCristina Valero, Mark Lee, Douglas Hoen, et al.Nature Communications|September 16, 2018
Autosomal genetic variation is associated with DNA methylation in regions variably escaping X-chromosome inactivationRené Luijk, Haoyu Wu, Cavin K Ward-Caviness, et al.Nature Medicine|April 24, 2019
Immunogenic neoantigens derived from gene fusions stimulate T cell responsesWei Yang, Ken-Wing Lee, Raghvendra M Srivastava, et al.Twin Research and Human Genetics : the Official Journal of the International Society for Twin Studies|November 5, 2013
Aging as accelerated accumulation of somatic variants: whole-genome sequencing of centenarian and middle-aged monozygotic twin pairsKai Ye, Marian Beekman, Eric-Wubbo Lameijer, et al.BMC Infectious Diseases|December 28, 2019
Study protocol for the multicentre cohorts of Zika virus infection in pregnant women, infants, and acute clinical cases in Latin America and the Caribbean: the ZIKAlliance consortiumVivian I Avelino-Silva, Philippe Mayaud, Adriana Tami, et al.Nature Genetics|July 11, 2022
Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunityXiaoxiao Ma, Nadeem Riaz, Robert M Samstein, et al.Journal of Extracellular Vesicles|July 26, 2018
Highlights of the São Paulo ISEV workshop on extracellular vesicles in cross-kingdom communicationRodrigo P Soares, Patrícia Xander, Adriana Oliveira Costa, et al.Nature Biotechnology|November 2, 2021
Improved prediction of immune checkpoint blockade efficacy across multiple cancer typesDiego Chowell, Seong-Keun Yoo, Cristina Valero, et al.Ebiomedicine|July 25, 2021
Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern FranceTom Woudenberg, Stéphane Pelleau, François Anna, et al.JAMA|April 15, 2020
Effect of a Chikungunya Virus-Like Particle Vaccine on Safety and Tolerability Outcomes: A Randomized Clinical TrialGrace L Chen, Emily E Coates, Sarah H Plummer, et al.Pageof 105